Associate Professor Ming Yew is a General, Endocrine and Breast Surgeon based in Perth, known for his commitment to excellence in surgical care and innovation. He has pioneered several Australian-first techniques, including transoral scarless thyroidectomy and prone retroperitoneoscopic adrenalectomy. In addition to his clinical work, Dr Yew has held significant leadership roles within the surgical community, serving as Head of Department, Chair of the Endocrine Tumour Board, Chair of the Royal Australasian College of Surgeons (RACS) State Committee, and as a RACS Federal Councillor. Driven by a desire to improve patient outcomes, he co-founded Inovamedical Pty Ltd, a medical device startup commercialising the Abcease device, which aims to transform the treatment of skin abscesses. Over the past nine years, the founding team has progressed through biodesign, pre-accelerator and accelerator programs, secured capital, and collaborated with bioengineering partners, patent lawyers, international patent offices, and the broader medtech industry.